Below are the most recent reports and articles from the RAND Drug Policy Research Center. Please visit our RAND Topics pages for a complete research archive on these and other drug policy-related research topics.
RAND Topic Pages: Drug Markets and SupplyThis paper assesses community perceptions of crime and the police before and after the implementation of an intervention aimed at eliminating overt drug markets through focused deterrence and police-community partnerships emphasizing racial reconciliation.
This paper combines complementary attributes of web and general population surveys to estimate cannabis consumption and spending in Washington State.
This article examines the cannabis market in Washington state post-legalization, and the variety of products available to consumers.
States that provide legal access to marijuana through dispensaries experience lower treatment admissions for addiction to pain medication.
Approximately 18.5 million Americans aged 12 or older reported buying marijuana in the past year; they were more likely to be male, report using marijuana for a greater number of days, and report dependence on marijuana.
In dealing with the opioid crisis, supply-side policies that consider the full market (both prescription opioids as well as heroin and fentanyl), if coupled with effective treatment, are likely to be the most effective.
The production and dissemination of sound evidence is a vital part of policy reform regarding the legalization of marijuana.
Analysis of marijuana price data in Colorado and Washington suggests that short-term evaluations of legalization's effects on marijuana consumption are not necessarily indicative of long-term effects.
The methods of contacting respondents and the technology for questioning respondents in household surveys complicate cross-country comparisons of drug prevalence.
State actions to relax marijuana policies vary substantially, making it difficult to compare policies and draw conclusions about user and market reactions.
